Exciting Investor Webcast Announced by Perimeter Medical Imaging AI, Inc.
TORONTO and DALLAS, Jan. 30, 2025 /PRNewswire/ – Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF)
“Perimeter” to Present Key Areas of Business During Webcast
Perimeter Medical Imaging AI, Inc., a leading medical technology company, has just announced an upcoming investor webcast hosted by Bristol Investor Relations. The event is scheduled to take place on Thursday, February 6, 2025 at 2:00 PM ET.
During the webcast, the CEO Adrian Mendes, CIO Andrew Berkeley, and CFO Sara Brien will be presenting on key areas of Perimeter’s business. Investors and stakeholders can expect to gain valuable insights into the company’s recent developments, future prospects, and innovative technologies.
This webcast is a great opportunity for investors to learn more about Perimeter Medical Imaging AI, Inc. and its potential for growth in the medical technology industry. With a focus on commercial-stage products and cutting-edge AI-driven solutions, Perimeter is poised for significant success in the coming years.
How This Announcement Will Impact Me:
As an investor, this webcast provides a unique opportunity to gain firsthand knowledge about Perimeter Medical Imaging AI, Inc. and its business strategies. By attending the event, I can stay informed about the company’s performance and make more informed decisions regarding my investment portfolio.
How This Announcement Will Impact the World:
Perimeter Medical Imaging AI, Inc.’s innovative technologies have the potential to revolutionize the field of medical imaging and improve patient outcomes on a global scale. By presenting key areas of their business during the webcast, Perimeter is showcasing their commitment to advancing medical technology and making a positive impact on healthcare worldwide.
Conclusion:
This investor webcast hosted by Perimeter Medical Imaging AI, Inc. promises to be an insightful event for investors and industry professionals alike. With a focus on innovation and growth, Perimeter is a company to watch in the rapidly-evolving medical technology sector.
